Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1338.50

3.10 (0.23%)

< Home < Back

Dr. Reddys Laboratories Ltd. News

>>

Dr. Reddy's Lab - Quaterly Results

>>

Dr. Reddy’s completes full set of clinical studies of rituximab biosimilar for filing in U.S., Europe

>>

Dr. Reddy’s Laboratories informs about press release

>>

Dr Reddy's reduces price of cardiovascular drug ‘Cidmus’

>>

Dr. Reddy’s acquires trademark rights of breast cancer drug PRIMCYV from Pfizer Products

>>

Dr. Reddy's inks pact with Theranica

>>

Dr. Reddy’s Laboratories informs about disclosure

>>

Dr. Reddy's Laboratories completes Phase 1 study of proposed biosimilar of Tocilizumab

>>

Dr.Reddy's Laboratories informs about press release

>>

Dr. Reddy's Laboratories’ arm enters into agreement to sell certain assets, liabilities

<< < 27 28 29 ...145 > >>